Target Name: TXNIP
NCBI ID: G10628
Other Name(s): TXNIP_HUMAN | Vitamin D3 up-regulated protein 1 | TXNIP variant 2 | upregulated by 1,25-dihydroxyvitamin D-3 | thioredoxin-interacting protein-like | THIF | thioredoxin binding protein 2 | Upregulated by 1,25-dihydroxyvitamin D-3 | Thioredoxin-interacting protein (isoform 1) | Thioredoxin binding protein 2 | Thioredoxin-binding protein 2 | Thioredoxin-interacting protein | EST01027 | Thioredoxin-interacting protein (isoform 2) | HHCPA78 | vitamin D3 up-regulated protein 1 | Thioredoxin interacting protein | thioredoxin interacting protein | VDUP1 | Thioredoxin interacting protein, transcript variant 1 | TXNIP variant 1 | ARRDC6 | Thioredoxin interacting protein, transcript variant 2

TXNIP: A protein involved in multiple cellular processes and potential drug targets

TXNIP (TXNIP_HUMAN), also known as transthyretin-to-nitric oxide (TON) binding protein, is a protein that is expressed in various tissues of the body, including the heart, lungs, kidneys, and intestines. It is a member of the superfamily of transmembrane proteins, which are a type of protein that spans the cell membrane and is involved in various cellular processes.

One of the unique features of TXNIP is its ability to interact with nitric oxide (NO), a molecule that plays a critical role in cardiovascular health. When NO is released from the endothelium (the lining of the blood vessels), it causes the blood vessels to relax and widen, leading to increased blood flow and improved cardiovascular health. TXNIP has been shown to play a key role in the regulation of NO signaling in various tissues of the body.

TXNIP is also involved in the regulation of inflammation and immune responses. It has been shown to play a critical role in the regulation of TNF-alpha (transforming growth factor-alpha), a protein that is involved in inflammation and immune responses. In addition, TXNIP has also been shown to play a key role in the regulation of IL-6 (interleukin-6), a protein that is involved in inflammation and immune responses.

TXNIP is also involved in the regulation of cellular signaling pathways that are important for various cellular processes, including cell division, apoptosis (programmed cell death), and angiogenesis (the formation of new blood vessels). It is also involved in the regulation of cellular signaling pathways that are important for stem cell biology, including the regulation of stem cell self-renewal and the differentiation of stem cells into functional tissues.

TXNIP is a protein that has the potential to be a drug target or biomarker for a variety of cardiovascular, respiratory, and neurological disorders. For example, TXNIP has been shown to be involved in the regulation of cardiovascular risk factors, including blood pressure, blood cholesterol, and the risk of cardiovascular disease. It is also involved in the regulation of respiratory function, including the regulation of airway resistance and the production of surfactant (a substance that helps to reduce surface tension and prevent airway collapse). In addition, TXNIP is involved in the regulation of neurological function, including the regulation of muscle tone and the production of neurotransmitters (such as dopamine and serotonin).

In conclusion, TXNIP is a protein that is involved in a variety of cellular processes that are important for various cellular functions. It is expressed in various tissues of the body and has been shown to play a critical role in the regulation of NO signaling, inflammation, and immune responses. The potential clinical applications for TXNIP as a drug target or biomarker are vast and varied. Further research is needed to fully understand its role in various cellular processes and its potential as a therapeutic agent.

Protein Name: Thioredoxin Interacting Protein

Functions: May act as an oxidative stress mediator by inhibiting thioredoxin activity or by limiting its bioavailability. Interacts with COPS5 and restores COPS5-induced suppression of CDKN1B stability, blocking the COPS5-mediated translocation of CDKN1B from the nucleus to the cytoplasm. Functions as a transcriptional repressor, possibly by acting as a bridge molecule between transcription factors and corepressor complexes, and over-expression will induce G0/G1 cell cycle arrest. Required for the maturation of natural killer cells. Acts as a suppressor of tumor cell growth. Inhibits the proteasomal degradation of DDIT4, and thereby contributes to the inhibition of the mammalian target of rapamycin complex 1 (mTORC1)

More Common Targets

TXNL1 | TXNL1P1 | TXNL4A | TXNL4B | TXNP6 | TXNRD1 | TXNRD2 | TXNRD3 | TXNRD3NB | TYK2 | TYMP | TYMS | TYMSOS | Type II Transmembrane serine protease | TYR | TYRO3 | TYRO3P | TYROBP | Tyrosine Kinase | Tyrosine-Protein Kinase ABL | Tyrosine-Protein Kinases Src | Tyrosyl-DNA phosphodiesterase TDP | TYRP1 | TYSND1 | TYW1 | TYW1B | TYW3 | U2 small nuclear ribonucleoprotein auxiliary factor | U2AF1 | U2AF1L4 | U2AF2 | U2SURP | U3 small nucleolar ribonucleoprotein (U3 snoRNP) complex | U5 small nuclear ribonucleoprotein complex | U7 snRNP complex | UACA | UAP1 | UAP1L1 | UBA1 | UBA2 | UBA3 | UBA5 | UBA52 | UBA52P1 | UBA6 | UBA6-DT | UBA7 | UBAC1 | UBAC2 | UBAC2-AS1 | UBALD1 | UBALD2 | UBAP1 | UBAP1L | UBAP2 | UBAP2L | UBASH3A | UBASH3B | UBB | UBBP1 | UBBP2 | UBBP4 | UBC | UBD | UBDP1 | UBE2A | UBE2B | UBE2C | UBE2CP3 | UBE2CP4 | UBE2D1 | UBE2D2 | UBE2D3 | UBE2D3P1 | UBE2D4 | UBE2DNL | UBE2E1 | UBE2E2 | UBE2E3 | UBE2F | UBE2F-SCLY | UBE2FP1 | UBE2G1 | UBE2G2 | UBE2H | UBE2HP1 | UBE2I | UBE2J1 | UBE2J2 | UBE2K | UBE2L1 | UBE2L3 | UBE2L6 | UBE2M | UBE2MP1 | UBE2N | UBE2NL | UBE2O | UBE2Q1 | UBE2Q2